Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.

Subjects

Subjects :

DEMENTIA risk factors
RISK assessment
METFORMIN
ALZHEIMER'S disease
RESEARCH funding
ENZYME inhibitors
SEX distribution
SCIENTIFIC observation
HYPOGLYCEMIC agents
DESCRIPTIVE statistics
TREATMENT effectiveness
VASCULAR dementia
AGE distribution
CARDIOVASCULAR diseases risk factors
SODIUM-glucose cotransporter 2 inhibitors
TYPE 2 diabetes
OSTEOARTHRITIS
COMPARATIVE studies
CONFIDENCE intervals
ADULTS

Details

Language :

English

ISSN :

17561833

Volume :

386

Issue :

8440

Database :

Complementary Index

Journal :

BMJ: British Medical Journal

Publication Type :

Academic Journal

Accession number :

179589638

Full Text :

https://doi.org/10.1136/bmj-2024-079475